Category: Markets
Published: 2026-07-16T11:26:45.000Z
Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform, aiming to enhance laboratory standardization for AI-driven cancer diagnostics. The acquisition is expected to close by the end of the year, with financial terms undisclosed.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.